Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

被引:0
|
作者
Alessandro Mantovani
Mario Luca Morieri
Luisa Palmisano
Maria Masulli
Efisio Cossu
Marco Giorgio Baroni
Katia Bonomo
Flavia Agata Cimini
Gisella Cavallo
Raffaella Buzzetti
Carmen Mignogna
Frida Leonetti
Simonetta Bacci
Roberto Trevisan
Riccardo Maria Pollis
Raffaella Aldigeri
Alessandra Dei Cas
Saula Vigili de Kreutzenberg
Giovanni Targher
机构
[1] University of Verona,Section of Endocrinology, Diabetes and Metabolism, Department of Medicine
[2] University of Padua,Metabolic Diseases, Department of Medicine
[3] Federico II University,Department of Clinical Medicine and Surgery
[4] Policlinico Universitario of Cagliari,Diabetology Unit
[5] University of Aquila,Department of Clinical Medicine, Life, Health and Environmental Sciences
[6] IRCCS Neuromed,Neuroendocrinology and Metabolic Diseases
[7] San Luigi Gonzaga University Hospital,Diabetes and Metabolic Diseases Unit
[8] Sapienza University,Department of Experimental Medicine
[9] Sapienza University,Department of Medical
[10] IRCCS Casa Sollievo della Sofferenza Hospital,Surgical Sciences and Biotechnologies
[11] University of Milan Bicocca,Section of Endocrinology, Department of Medicine
[12] Azienda Ospedaliero-Universitaria,Department of Medicine and Surgery
[13] University of Parma,Division of Nutritional and Metabolic Sciences
[14] IRCCS Sacro Cuore Don Calabria Hospital,Department of Medicine and Surgery
[15] University and Azienda Ospedaliera Universitaria Integrata,Section of Endocrinology, Diabetes and Metabolism, Department of Medicine
来源
Cardiovascular Diabetology | / 22卷
关键词
NAFLD; Non-alcoholic fatty liver disease; T1DM; Type 1 diabetes; CVD; Cardiovascular disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
    Mantovani, Alessandro
    Morieri, Mario Luca
    Palmisano, Luisa
    Masulli, Maria
    Cossu, Efisio
    Baroni, Marco Giorgio
    Bonomo, Katia
    Cimini, Flavia Agata
    Cavallo, Gisella
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Pollis, Riccardo Maria
    Aldigeri, Raffaella
    Cas, Alessandra Dei
    de Kreutzenberg, Saula Vigili
    Targher, Giovanni
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
    Mantovani, Alessandro
    Morieri, Mario Luca
    Aldigeri, Raffaella
    Palmisano, Luisa
    Masulli, Maria
    Bonomo, Katia
    Baroni, Marco Giorgio
    Cossu, Efisio
    Cimini, Flavia Agata
    Cavallo, Gisella
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Pollis, Riccardo Maria
    Dei Cas, Alessandra
    Kreutzenberg, Saula Vigili de
    Targher, Giovanni
    DIABETES & METABOLISM, 2024, 50 (01)
  • [3] 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
    Gyldenkerne, Christine
    Mortensen, Martin Bodtker
    Kahlert, Johnny
    Thrane, Pernille Gro
    Olesen, Kevin Kris Warnakula
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    Maeng, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (16) : 1583 - 1594
  • [4] Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease
    McVeigh, G. E.
    Gibson, W.
    Hamilton, P. K.
    DIABETES OBESITY & METABOLISM, 2013, 15 (03) : 198 - 203
  • [5] Association of Kidney Function With 10-Year Risk of Atherosclerotic Cardiovascular Disease , Cardiovascular Disease and Its Risk Factors Among Women With Type 2 Diabetes Mellitus
    Siddiqui, Khalid
    George, Teena P.
    Mujammami, Muhammad
    Alfadda, Assim A.
    Nawaz, Shaik Sarfaraz
    Rafiullah, Mohamed
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2025, 17 : 449 - 457
  • [6] Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk
    Gui, Zihao
    Chen, Xingying
    Wang, Dongmei
    Chen, Zhi
    Liu, Siyang
    Yu, Genfeng
    Jiang, Yuqi
    Duan, Hualin
    Pan, Daoyan
    Lin, Xu
    Liu, Lan
    Wan, Heng
    Shen, Jie
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [7] Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations
    Yew, Sheng Qian
    Chia, Yook Chin
    Theodorakis, Michael
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2019, 31 (07) : 622 - 632
  • [8] Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
    Chhabra, Sandeep
    Singh, Arshdeep
    Mehta, Varun
    Kaur, Amninder
    Bansal, Namita
    Sood, Ajit
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 409 - 416
  • [9] Prevalence of metabolic risk factors and associated 10-year prediction of cardiovascular disease and diabetes in female employees
    Gray, Benjamin J.
    Bracken, Richard M.
    Turner, Daniel
    Morgan, Kerry
    Mellalieu, Stephen D.
    Thomas, Michael
    Williams, Sally P.
    Williams, Meurig
    Rice, Sam
    Stephens, Jeffrey W.
    PRACTICAL DIABETES, 2014, 31 (07) : 281 - 285
  • [10] Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
    Zhao, Shuo
    Liu, Ming-Li
    Huang, Bing
    Zhao, Fu-Rong
    Li, Ying
    Cui, Xue-Ting
    Lin, Rong
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12